Skip to main content
Account

Peer review reports

From: KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data

Original Submission
12 May 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Jun 2021 Reviewed Reviewer Report
24 Jun 2021 Reviewed Reviewer Report
26 Jul 2021 Author responded Author comments - Shu-lin Liu
Resubmission - Version 3
26 Jul 2021 Submitted Manuscript version 3
20 Aug 2021 Author responded Author comments - Shu-lin Liu
Resubmission - Version 4
20 Aug 2021 Submitted Manuscript version 4
25 Aug 2021 Author responded Author comments - Shu-lin Liu
Resubmission - Version 5
25 Aug 2021 Submitted Manuscript version 5
27 Aug 2021 Author responded Author comments - Shu-lin Liu
Resubmission - Version 6
27 Aug 2021 Submitted Manuscript version 6
15 Sep 2021 Reviewed Reviewer Report
7 Oct 2021 Reviewed Reviewer Report
2 Mar 2022 Author responded Author comments - Shu-lin Liu
Resubmission - Version 7
2 Mar 2022 Submitted Manuscript version 7
7 Mar 2022 Author responded Author comments - Shu-lin Liu
Resubmission - Version 8
7 Mar 2022 Submitted Manuscript version 8
Publishing
9 Jun 2022 Editorially accepted
16 Jun 2022 Article published 10.1186/s12885-022-09747-2

Learn about peer review

Back to article page

Navigation